Traynor Capital Management, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1666786
MALVERN, PA
Position in REGN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,873,737
-$22,438,153 QoQ
Shares Held
3,005
-90.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#528
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Dec 31, 2025CallValue
$308,748
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $9,749,803 across 5 Biotechnology names. REGN ranks #3 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,049 | $4,494,909 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,458 | $3,148,171 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,005 | $1,873,737 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
19,200 | $168,096 | |
| 5 | NGEN |
Nervgen Pharma Corp.
|
31,500 | $64,890 |
All Filings in REGN
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,873,737 | 3,005 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $24,311,890 | 31,466 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $308,748 | 400 | Call | Sole | 2026-01-12 | |
| 2025-12-31 | $24,208,158 | 31,363 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $17,209,960 | 30,608 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $15,476,475 | 29,479 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $17,667,110 | 27,856 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $17,658,660 | 24,790 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $23,537,263 | 22,390 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $21,355,878 | 20,319 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $19,005,327 | 19,746 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $16,571,575 | 18,868 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $14,978,694 | 18,201 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $12,586,665 | 17,517 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $13,891,974 | 16,907 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $11,366,353 | 15,754 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $12,511,945 | 18,163 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $10,632,655 | 17,987 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $12,532,448 | 17,944 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $10,908,244 | 17,273 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $9,069,227 | 14,986 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $7,590,558 | 13,590 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $5,981,909 | 12,643 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $5,875,100 | 12,161 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $5,716,473 | 10,212 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $5,941,513 | 9,527 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,030,816 | 6,207 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||